LM
Liana Moussatos Wedbush Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
VRNA
1
Verona Pharma
VRNA
$9.2B
| $106.41 | $33 |
69%
downside
| Outperform | 1 year ago |
|
2
United Therapeutics
UTHR
$17.6B
| $388.82 | $308 |
21%
downside
| Outperform | 1 year ago |
|
3
Liquidia Corp
LQDA
$2.51B
| $29.15 | $3 |
90%
downside
| Underperform | 3 years ago |
|
4
Ascendis Pharma
ASND
$12.5B
| $205.92 | $117 |
43%
downside
| Outperform | 3 years ago |
|
5
Pacira BioSciences
PCRX
$1.19B
| $26.48 | $94 |
255%
upside
| Outperform | 3 years ago |
|
6
Xoma
XOMA
$429M
| $35.51 | $22 |
38%
downside
| Neutral | 4 years ago |
|
7
Lexicon Pharmaceuticals
LXRX
$400M
| $1.10 | $8 |
627%
upside
| Neutral | 4 years ago |
|
8
BioMarin Pharmaceuticals
BMRN
$11.1B
| $57.66 | $164 |
184%
upside
| Outperform | 5 years ago |
|
9
Aquestive Therapeutics
AQST
$648M
| $5.36 | $36 |
572%
upside
| Outperform | 5 years ago |
|